HEERLEN, Netherlands, May 19, 2021 /PRNewswire/ -- Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, today announces that it will redeem the €500 million 1.375% bond earlier than its scheduled maturity of 26 September 2022, in accordance with its terms and conditions. The bond was issued on 24 September 2015, under Prospectus dated 24 March 2015 of Koninklijke DSM N.V. (ISIN: XS1293087703) (the "Notes").
Notice is hereby given that DSM exercises its right to redeem all of the Notes early, in full, on the Make Whole Redemption Date falling on 18 June 2021, pursuant to Condition 5(d)(iii) of the Terms and Conditions of the Notes (Issuer Make-whole Redemption Call). The Notes will be redeemed at the Make-whole Redemption Amount calculated in accordance with Condition 5(d)(iii) of the Terms and Conditions of the Notes. The last day of trading will be 17 June 2021.
DSM - Bright Science. Brighter Living.
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM's purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world's biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders - customers, employees, shareholders, and society at large. DSM delivers innovative solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 23,000 employees. The company was founded in 1902 and is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
Or find us on:
Facebook: http://www.facebook.com/DSMcompany
Twitter: http://www.twitter.com/DSM
LinkedIn: http://www.linkedin.com/company/3108
YouTube: http://www.youtube.com/user/dsmcompany
For more information:
DSM Media relations Lieke de Jong tel. +31 (0) 45 5782420 email media.contacts@dsm.com | DSM Investor Relations Dave Huizing tel. +31 (0) 45 5782864 email investor.relations@dsm.com |
Forward-looking statements
This press release may contain forward-looking statements with respect to DSM's future (financial) performance and position. Such statements are based on current expectations, estimates and projections of DSM and information currently available to the company. DSM cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. DSM has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is leading.
Logo - https://mma.prnewswire.com/media/329419/dsm_logo.jpg
